Tag: drugs

Top Medical News Stories of 2011

1. FDA Calls for Simvastatin Limits The FDA played a role in most of this year’s top news stories, starting with a June 8 recommendation that physicians restrict prescribing high doses of the cholesterol medication simvastatin (Zocor, Merck) because of a risk for muscle damage. The FDA drug safety communication states that physicians should limit using the…

Read More

Metformin Curbs Ovarian Hyperstimulation in PCOS

Metformin cuts the risk of overstimulating the ovaries of women who have polycystic ovary syndrome (PCOS) and are receiving gonadotropin for in vitro fertilization, Italian researchers report in a paper online October 10 in Fertility and Sterility. Ovarian hyperstimulation syndrome, or OHSS, is a rare iatrogenic condition in which the ovaries grow and, in advanced…

Read More

A 3-Year Holiday From Bisphosphonates Appears Safe

Bone mineral density held steady in women who took a 3-year hiatus from bisphosphonate therapy, according to a new study presented this past weekend at the 20th annual meeting and clinical congress of the American Association of Clinical Endocrinologists (AACE). “Current AACE guidelines on osteoporosis recommend a drug holiday from bisphosphonates after 4 or 5…

Read More

FDA Says Pharmacies Can Still Compound Generic Makena

Pharmacies can continue to compound generic hydroxyprogesterone caproate for reducing the risk for preterm delivery despite warnings from KV Pharmaceutical — which sells a costly, branded version of the drug — not to do so, the US Food and Drug Administration (FDA) announced today. On February 3, the FDA approved KV Pharmaceutical’s Makena, an injectable form of hydroxyprogesterone…

Read More
© 2024 Neera Bhatia MD OBGYN. All Rights Reserved. San Antonio Website Design & Development - Backyard Studios